
Phaos Technology Holdings (Caym
POASAMEXHealthcareMedical - Devices
前收盤價
US$0.1613
+US$0.0009 · +0.56%
盤前
US$0.16
−US$0.0013 · -0.81%
8月24日 上午7:47 ET
POAS公司概覽
盤中時間採用ET。市場資料可能有所延遲。
GoAI 研究快照
簡明呈現最新可用的模型資訊。
GoAI評分
Strong Sell
Exit — multiple negative signals converging
估值
10
Overpriced
動能
19
Strong Down
情緒
51
Mixed
風險韌性
14
Extreme Risk
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
人工智慧產生的上下文僅供參考,並非投資建議。
公司概況
公司網站Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
- 產業
- Medical - Devices
- 部門
- Healthcare
- 總部
- SG
- 執行長
- Hong Loon Gan
- 上市以來
- 2025年11月13日
- 僱員
- 10
市場位置
日內區間
目前US$0.1613,
52週區間
目前US$0.1613,
- 開盤價
- US$0.1606
- 前收盤價
- US$0.1604
- 成交量
- 14.78萬
- 0.14× 平均值
- 平均成交量
- 105.94萬
- 日均成交量
- 市值
- 221.1萬 USD
- 貝塔
- 2.74
- 市場參考 1
- 50天平均值
- US$0.2406
- 低於平均水平-32.97%
- 200天平均值
- US$2.0491
- 低於平均水平-92.13%
財務數據
財務快照
最近十二個月估值與收益率
- 企業價值
- 6704.75萬 SGD
- 本益比(TTM)
- -0.53×
- 股價淨值比(TTM)
- -1.39×
- 股價營收比(TTM)
- 16.74×
- EV/EBITDA
- -13.57×
- 盈餘收益率
- -7.68%
- 自由現金流收益率
- -5.82%
- 股息率
- 0.00%
獲利能力和效率
- 毛利率
- 22.10%
- 營業利益率
- -3148.28%
- 淨利潤率
- -3063.12%
- 股東權益報酬率
- 261.72%
- 資產報酬率
- -265.61%
- 投入資本報酬率
- 311.13%
財務健康
- 負債權益比
- -0.14×
- 流動比率
- 0.4×
財務報表
利潤率趨勢
獲利能力占已公布營收的百分比。
損益趨勢
營收
營業利益
淨利
| 項目(SGD) | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|
| 營收 | 16.77萬 SGD | 188.28萬 SGD | 65.08萬 SGD |
| 銷貨成本 | 13.06萬 SGD | 98.51萬 SGD | 53.62萬 SGD |
| 毛利 | 3.71萬 SGD | 89.77萬 SGD | 11.46萬 SGD |
| 研究與開發 | 13.97萬 SGD | 9.06萬 SGD | 2.7萬 SGD |
| 銷售、一般及管理費用 | 328.3萬 SGD | 209.27萬 SGD | 159.12萬 SGD |
| 營業費用 | 531.7萬 SGD | 340.08萬 SGD | 215.68萬 SGD |
| 利息收入 | 5832 SGD | — | — |
| 利息支出 | 8463 SGD | 4.35萬 SGD | 2.51萬 SGD |
| 折舊和攤銷 | 18.7萬 SGD | 17.67萬 SGD | 19.56萬 SGD |
| 營業利益 | −527.99萬 SGD | −250.31萬 SGD | −204.22萬 SGD |
| 淨利 | −513.71萬 SGD | −235.98萬 SGD | −166.78萬 SGD |
公司資料更新於 2026年8月24日。
POAS同業公司
繼續GoAI的研究
在 GoAI 中研究POASresearch.disclaimer





